Real‐world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study by Middleton, M, Dalle, S, Claveau, J, Mut, P, Hallmeyer, S, Plantin, P, Highley, M, Kotapati, S, Le, T, Brokaw, J, Abernethy, A

Long-term real-world (RW) outcomes in patients with advanced melanoma (MEL) treated with ipilimumab (IPI) and non-IPI therapies: IMAGE study by Dalle, S, Mortier, L, Corrie, P, Lotem, M, Board, R, Arance, A, Meiss, F, Terheyden, P, Gutzmer, R, Brokaw, J, Le, T, Mathias, S, Scotto, J, Lord-Bessen, J, Moshyk, A, Kotapati, S, Middleton, M

Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study by Dalle, S, Mortier, L, Corrie, P, Lotem, M, Board, R, Arance, AM, Meiss, F, Terheyden, P, Gutzmer, R, Buysse, B, Oh, K, Brokaw, J, Le, TK, Mathias, SD, Scotto, J, Lord-Bessen, J, Moshyk, A, Kotapati, S, Wilkinson, J